Search

Background: Depression is the most common psychiatric disorder in patients with epilepsy. The aim of this study was to determine the prevalence of depressive symptoms and its factors associated in patients with epilepsy at the Yalgado Ouedraogo University Teaching Hospital (Burkina Faso). Methods: This was a prospective 6-month study carried out in Neurology Department from February to July 2017. This study included all the patients with epilepsy aged over 18 years. Sampling was non-random with systematic recruitment. The informed consent of the patient was required. All included patients were assessed using the Hamilton Depression Scale and Gererd questionnaire. The analysis of the data was performed by the software Epi Info version 7. Results: One hundred two patients with epilepsy with a mean age of 41.47 ± 16.67 years were included. The symptoms of depression were present in 67.3% of patients with epilepsy with a mean age of 42.59 ± 17 years, and 78 years (19 - 88 years). Depression was mild in 35%, moderate in 34% and severe in 31%. The prevalence of depressive symptoms was respectively 57.6% in male patients and 79% in female gender. The mean score of HDRS for depression was 15.62 ± 4.26. Hypochondriasis (97%), work and interest (95.5%) and anxiety-somatic (94.1%) were the most symptoms of HDRS-17. Higher scores were found for work and interests, anxiety-psychic and hypochondriasis. There was a significant association between perceived stigma, female gender, seizure frequency and presence of depression among patients with epilepsy (p < 0.05). Conclusion: Our study had found a high prevalence of depression among patients with epilepsy. High perceived stigma, female gender and seizure frequency were the most associated factors with depressive symptoms.

Objective: To study the frequency and factors associated with depression in rheumatoid arthritis (RA) among Black African patients. Patients and methods: It was a case-control study with a group of patients with RA (case) and a group of healthy subjects without rheumatoid arthritis (con-trols) matched by age and sex. All patients admitted to the rheumatologic department during February 2015 to July 2015 for rheumatoid arthritis meeting the criteria ACR/EULAR 2010, were included. Patients with high blood pressure, diabetes mellitus, renal failure or HIV infection have been excluded. Depression was assessed by the Hamilton Rating Scale for Depression. Results: Fifty patients with RA were included and compared to 100 healthy controls. For RA patients, it was 39 (78%) female and 11 (22%) male with a sex ratio of 0.28. In the control group, it was 77 (77%) female and 23 (23%) male with a sex ratio of 0.29. Twenty-seven (54%) patients with RA had depression compared with 17 (17%) subjects in the control group (p = 0.000). Impaired quality of life and a DAS 28 score greater than 3.2 were statistically associated with depression during RA with a p value respectively of 0.021 and 0.0000231. Conclusion: Depres-sion is significantly more common during RA than in non-RA controls. RA patients should be screened routinely for depression in order to ensure improved treatment and management.